Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Jardiance and its CV data? They're no knockout punch for stalwart Januvia, Merck says
Fierce Pharma
Wed, 09/2/15 - 10:27 am
Tags:
Jardiance, diabetes, Eli Lilly, Boehringer Ingelheim, Merck, Januvia
Did This Clinical Study Just Show Merck's Best-Selling Drug the Door?
Motley Fool
Sun, 08/30/15 - 11:54 am
Tags:
Merck, clinical trials, Januvia, Janumet, Eli Lilly, Boehringer Ingelheim, SGLT2 inhibitor, Jardiance
Lilly, Boehringer amp up fight against Lantus with U.K. biosim launch
Fierce Pharma
Sat, 08/29/15 - 08:57 am
Tags:
Lantus, Eli Lilly, biosimilars, diabetes, Boehringer Ingelheim, Sanofi
Eli Lilly's marginal cancer drug becomes Exhibit A in pricing debate
Fierce Biotech
Sat, 08/29/15 - 08:56 am
Tags:
Eli Lilly, drug pricing, necitumumab, non-small cell lung cancer
Novo Nordisk buys diabetes startups founded by Lilly R&D veteran
Fierce Biotech
Fri, 08/28/15 - 09:51 am
Tags:
Novo Nordisk, M&A, Eli Lilly, R&D, diabetes, Calibrium, MB2
Eli Lilly's Diabetes Drug May Halt Heart Disease
Motley Fool
Fri, 08/28/15 - 08:18 am
Tags:
Eli Lilly, Jardiance, stroke, diabetes, Boehringer Ingelheim
Court Rules In Lilly's Favor On Alimta Vitamin Regimen Patent
NASDAQ.com
Wed, 08/26/15 - 08:50 am
Tags:
Eli Lilly, Alimta, Teva Pharmaceutical, patents
Eli Lilly Leads US Large Pharma Stocks In 2015; Johnson & Johnson Ranks Lowest
Bidness, ETC
Wed, 08/26/15 - 08:46 am
Tags:
JNJ, Eli Lilly, pharma stocks
Lilly, Sanofi, Novo among many pharma players to throw off big price gains in H1
Fierce Pharma
Sat, 08/22/15 - 08:48 am
Tags:
Sanofi, Novo Nordisk, Eli Lilly, AstraZeneca, GSK, JNJ, stock prices
Merck’s Diabetes Dominance at Risk as Rival Drug Helps Out Heart
Bloomberg
Fri, 08/21/15 - 05:24 pm
Tags:
Merck, Januvia, Janumet, diabetes, Jardiance, Eli Lilly, Boehringer Ingelheim
The 2013 Merck-Pfizer Diabetes Deal Now Looks Very Savvy
Forbes
Thu, 08/20/15 - 03:14 pm
Tags:
Merck, Pfizer, diabetes, Jardiance, Januvia, ertugliflozin, Eli Lilly
Lilly, Boehringer diabetes drug reduces cardiovascular risk in trial
Yahoo/Reuters
Thu, 08/20/15 - 08:26 am
Tags:
Eli Lilly, Boehringer Ingelheim, Jardiance
Will pricey new drug classes take the wind out of diabetes launches?
Fierce Pharma Marketing
Wed, 08/19/15 - 10:01 am
Tags:
diabetes, Novo Nordisk, Eli Lilly, Boehringer Ingelheim, Sanofi
4 Top Pharma Stocks That Should Outperform Out To 2016
24/7 Wall St
Tue, 08/18/15 - 09:44 am
Tags:
AbbVie, Bristol-Myers Squibb, Eli Lilly, Merck
Lilly's CEO keeps faith in the pipeline as biotech gets 'too expensive'
Fierce Biotech
Fri, 08/14/15 - 11:34 am
Tags:
Eli Lilly, Pharma CEOs, John Lechleiter
Eli Lilly Wins First Trial Over Antidepressant ‘Brain Zaps’
Bloomberg
Sat, 08/8/15 - 01:14 pm
Tags:
Eli Lilly, antidepressants, Cymbalta, withdrawal symptoms
Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study
Yahoo
Wed, 08/5/15 - 09:00 am
Tags:
R&D, Eli Lilly, Alzheimer's disease
Eli Lilly faces first U.S. trials over Cymbalta withdrawal
Yahoo/Reuters
Tue, 08/4/15 - 08:19 am
Tags:
Eli Lilly, Cymbalta, withdrawal symptoms, clinical trials, antidepressants
Eli Lilly’s Solanezumab: A Possible Cure for Alzheimer’s?
Yahoo/Market Realist
Tue, 07/28/15 - 10:20 am
Tags:
Eli Lilly, solanezumab, Alzheimer's disease
Eli Lilly soldiers on in big PhIII evacetrapib study
Fierce Biotech
Mon, 07/27/15 - 10:03 am
Tags:
Eli Lilly, clinical trials, evacetrapib

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.